# Bupropion for the Prevention of Postpartum Smoking Relapse

> **NCT04098874** · PHASE4 · RECRUITING · sponsor: **University of Minnesota** · enrollment: 200 (estimated)

## Conditions studied

- Postpartum Smoking Relapse

## Interventions

- **DRUG:** Bupropion Extended Release Oral Tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04098874
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04098874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04098874, "Bupropion for the Prevention of Postpartum Smoking Relapse". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04098874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*